Editor’s note: This is a previously posted video, and the below is an automatically generated transcript to be used for informational purposes. Please notify editor@healio.com if there are concerns ...
At the 2024 annual meeting of the International Society for Cell & Gene Therapy (ISCT) in Vancouver, Canada, Hélio Tomás, PhD, senior research associate at the Instituto de Biologia Experimental e ...
Chimeric antigen receptor (CAR) T-cell and T-cell receptor (TCR) T-cell therapies are promising treatments for a range of cancers, offering hope to patients whose cancers have become refractory to ...
According to Kite, the median turnaround time for Yescarta is expected to be reduced from 16 days to 14 days. The Food and Drug Administration (FDA) has approved a manufacturing process change for ...
TOKYO & MONT-SAINT-GUIBERT, Belgium--(BUSINESS WIRE)--BrightPath Bio (Tokyo Stock Exchange Growth 4594, “BrightPath”), a pioneer in iPS cell-derived Natural Killer T (“NKT”) cell therapy, and ...
Dongfeng Motor has officially signed a partnership with Ubtech Robotics for using its humanoid robots in tasks related to car manufacturing. With this partnership, Ubtech’s industrial version of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results